Black Rock Inc. Arbutus Biopharma Corp Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Black Rock Inc. holds 11,552,066 shares of ABUS stock, worth $44.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,552,066

Previous 10,404,619 11.03%

Holding current value

$44.7 Million

Previous $26.8 Million 32.98%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.52 - $3.63 $2.89 Million - $4.17 Million	1,147,447 Added 11.03%	11,552,066 $35.7 Million
Q1 2024 May 10, 2024	BUY	$2.26 - $2.92 $32,360 - $41,811	14,319 Added 0.14%	10,404,619 $26.8 Million
Q4 2023 Feb 13, 2024	BUY	$1.69 - $2.54 $196,308 - $295,043	116,159 Added 1.13%	10,390,300 $26 Million
Q3 2023 Nov 13, 2023	BUY	$1.9 - $2.27 $578,766 - $691,473	304,614 Added 3.06%	10,274,141 $20.9 Million
Q2 2023 Aug 11, 2023	BUY	$2.24 - $3.06 $3.37 Million - $4.61 Million	1,505,441 Added 17.79%	9,969,527 $22.9 Million
Q1 2023 May 12, 2023	SELL	$2.23 - $3.1 $526,962 - $732,548	-236,306 Reduced 2.72%	8,464,086 $25.6 Million
Q4 2022 Feb 13, 2023	BUY	$1.91 - $2.85 $2.35 Million - $3.51 Million	1,232,574 Added 16.51%	8,700,392 $20.3 Million
Q3 2022 Nov 14, 2022	SELL	$1.88 - $2.88 $136,420 - $208,984	-72,564 Reduced 0.96%	7,467,818 $14.3 Million
Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $1.42 Million - $2.27 Million	715,553 Added 10.48%	7,540,382 $20.4 Million
Q1 2022 May 12, 2022	BUY	$2.42 - $3.98 $1.59 Million - $2.62 Million	658,480 Added 10.68%	6,824,829 $20.3 Million
Q4 2021 Feb 10, 2022	BUY	$3.11 - $4.61 $718,864 - $1.07 Million	231,146 Added 3.89%	6,166,349 $24 Million
Q3 2021 Nov 09, 2021	BUY	$2.65 - $4.62 $264,019 - $460,290	99,630 Added 1.71%	5,935,203 $25.5 Million
Q2 2021 Aug 11, 2021	BUY	$2.5 - $3.51 $14.6 Million - $20.5 Million	5,835,573 New	5,835,573 $17.7 Million

Others Institutions Holding ABUS

# of Institutions

138

Shares Held

95.4M

Call Options Held

3.44M

Put Options Held

377K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $580M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account